News

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, ...
Guselkumab treatment was associated with improvements in 3 biomarkers associated with systemic inflammation among patients with plaque psoriasis.
Teva and Alvotech announced that the U.S. Food and Drug Administration (FDA) approved SELARSDI (ustekinumab-aekn) injection as ...
Learn to distinguish between nail psoriasis and nail fungus through key visual differences, associated symptoms, and ...
Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.
Medically reviewed by Katlein Franca, MD Nail psoriasis and onychomycosis (nail fungus) are both conditions that can discolor ...
The U.K.’s Medicines and Healthcare products Regulatory Agency has approved guselkumab, or Tremfya, to treat Crohn’s disease ...
What is Trichodynia? Trichodynia, often called scalp dysesthesia, is a condition marked by discomfort or pain in the scalp. At first, it was thought to be caused by hair loss activity or inflammation ...
Stull said that a number of prescription treatments exist for topical psoriasis, such as steroids and injectable therapies, ...
Turmeric, a common spice, has been used in Eastern medicine for centuries. Studies are now examining the benefits of yellow ...
Roflumilast foam, 0.3%, proved to be a simplified treatment regimen with high efficacy for patients with scalp and body ...
Discover why your skin develops scaling patches, from common dry skin to medical conditions requiring treatment, plus ...